Oncologists discuss leading and emerging treatment options for patients with blood cancers, including Mantle Cell Lymphoma.

In this video, Dr. Tycel Phillips discusses Acalabrutinib and Zanubrutinib in the second line setting.

Thanks to our sponsors Lilly Oncology, Abbvie, and Pharmacyclics

For more, please visit [ Ссылка ].
To join the conversation, visit [ Ссылка ].

свернуть